http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109045002-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 |
| filingDate | 2018-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-109045002-B |
| titleOfInvention | Amide compound in medlar and application of composition thereof |
| abstract | The invention discloses an amide compound with tyrosinase activation activity and an amide compound component, wherein the amide compound with tyrosinase activation activity and the amide compound component are extracted from Chinese wolfberry, the amide compound has the application of treating leucoderma, the amide compound and the amide compound component have good tyrosinase activation activity and the effect of treating leucoderma, a research thought is provided for treating leucoderma, and a pharmacological basic support is provided for the development of leucoderma treatment medicines. |
| priorityDate | 2018-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 67.